Treace Medical Concepts (TMCI) Interest & Investment Income (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Interest & Investment Income came in at $501000.0 in Q1 2026, down 40.43% YoY from $841000.0 in Q1 2025, and down 4.93% on a QoQ basis from $527000.0 in Q4 2025.
Treace Medical Concepts (TMCI) Interest & Investment Income (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 7 years of Interest & Investment Income data on file, last reported at $501000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 40.43% year-over-year to $501000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (down 41.74% YoY) and the FY2025 annual result came in at $2.8 million, down 43.06% from the prior year.
- Interest & Investment Income retreated to $501000.0 in Q1 2026, from $527000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $2.0 million in Q2 2023 to a low of $9000.0 in Q1 2022.
- A 5-year average of $952588.2 and a median of $841000.0 in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income surged 16333.33% — and 2024, when it sank 47.4%.
- Tracing TMCI's Interest & Investment Income over 5 years: stood at $753000.0 in 2022, then surged by 126.96% to $1.7 million in 2023, then sank by 47.4% to $899000.0 in 2024, then slumped by 41.38% to $527000.0 in 2025, then decreased by 4.93% to $501000.0 in 2026.
- The last three Interest & Investment Income figures came in at $501000.0 (Q1 2026), $527000.0 (Q4 2025), and $634000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | - |
| 10 | Treace Medical Concepts | 285.57 Mn | 239.95 Mn | 35.61 Mn | 445,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 445,000.00 |
| Mar 31, 2026 | 501,000.00 |
| Dec 31, 2025 | 527,000.00 |
| Sep 30, 2025 | 634,000.00 |
| Jun 30, 2025 | 775,000.00 |
| Mar 31, 2025 | 841,000.00 |
| Dec 31, 2024 | 899,000.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 1.97 Mn |
| Mar 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 753,000.00 |
| Sep 30, 2022 | 420,000.00 |
| Jun 30, 2022 | 131,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 5,000.00 |